摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,13-bis(bis(3,5-dimethylphenyl)phosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine | 337359-59-8

中文名称
——
中文别名
——
英文名称
1,13-bis(bis(3,5-dimethylphenyl)phosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine
英文别名
1,13-bis(bis(3,5-dimethylphenyl)phosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonin;(+)-xylyl-C3-TUNEPHOS;[17-Bis(3,5-dimethylphenyl)phosphanyl-8,12-dioxatricyclo[11.4.0.02,7]heptadeca-1(13),2(7),3,5,14,16-hexaen-3-yl]-bis(3,5-dimethylphenyl)phosphane;[17-bis(3,5-dimethylphenyl)phosphanyl-8,12-dioxatricyclo[11.4.0.02,7]heptadeca-1(13),2(7),3,5,14,16-hexaen-3-yl]-bis(3,5-dimethylphenyl)phosphane
1,13-bis(bis(3,5-dimethylphenyl)phosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine化学式
CAS
337359-59-8
化学式
C47H48O2P2
mdl
——
分子量
706.844
InChiKey
CJVIXZONXCRJSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.9
  • 重原子数:
    51
  • 可旋转键数:
    6
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]21,13-bis(bis(3,5-dimethylphenyl)phosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine甲醇 为溶剂, 反应 2.0h, 生成 [RuCl(p-cymene)((+)-xylyl-c3-tunephos)]Cl
    参考文献:
    名称:
    [EN] RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND
    [FR] COMPLEXE DE RUTHÉNIUM ET PROCÉDÉ POUR PRÉPARER UN COMPOSÉ ALCOOLIQUE OPTIQUEMENT ACTIF
    摘要:
    本发明提供了一种新型钌配合物,其在对羰基化合物的不对称还原反应活性和对映选择性方面具有优异的催化活性,以及使用该钌配合物的催化剂和制备光学活性醇化合物的方法。本发明涉及具有钌环结构的钌配合物,由该钌配合物组成的不对称还原催化剂,以及使用该钌配合物制备光学活性醇的方法。
    公开号:
    WO2011135753A1
点击查看最新优质反应信息

文献信息

  • PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE
    申请人:TAKASAGO INTERNATIONAL CORPORATION
    公开号:US20150210657A1
    公开(公告)日:2015-07-30
    A process for producing an optically active amine compound, characterized by asymmetrically hydrogenating a prochiral carbon-nitrogen double bond in the presence of a ruthenium complex represented by general formula (1) or (2) (wherein P represents an optically active diphosphine, X represents an anionic group, and Ar represents an optionally substituted arylene group).
    一种制备光学活性胺化合物的方法,其特征在于在存在由通用式(1)或(2)表示的钌配合物的情况下,对一个丙半胱氨基双键进行不对称氢化(其中P代表光学活性二膦,X代表阴离子基团,Ar代表可选择取代的芳基基团)。
  • RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND
    申请人:Nara Hideki
    公开号:US20130041151A1
    公开(公告)日:2013-02-14
    The present invention provides a novel ruthenium complex which has an excellent catalytic activity in terms of reactivity for asymmetric reduction of a carbonyl compound and enantioselectivity, a catalyst using the ruthenium complex, and a method for preparing optically active alcohol compounds using the ruthenium complex. The present invention relates to a ruthenium complex having ruthenacycle structure, a catalyst for asymmetric reduction consisting of the ruthenium complex, and a method for preparing optically active alcohol using the ruthenium complex.
    本发明提供了一种新型的钌配合物,该配合物在对羰基化合物的不对称还原反应中具有优异的催化活性和对映选择性,以及使用该钌配合物的催化剂和制备光学活性醇化合物的方法。本发明涉及一种具有钌环结构的钌配合物,一种由该钌配合物组成的不对称还原催化剂,以及使用该钌配合物制备光学活性醇的方法。
  • NOVEL RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND USING SAME AS CATALYST
    申请人:Hori Kiyoto
    公开号:US20140187809A1
    公开(公告)日:2014-07-03
    The present invention provides a novel ruthenium complex which has an excellent catalytic activity in terms of reactivity for an asymmetric reduction of a carbonyl compound and enantioselectivity, a catalyst using the ruthenium complex, and a method for preparing optically active alcohol compounds using the ruthenium complex. The present invention relates to a ruthenium complex having a ruthenacycle structure, a catalyst for an asymmetric reduction consisting of the ruthenium complex, and a method for preparing optically active alcohol compounds using the ruthenium complex.
    本发明提供了一种新型的钌配合物,其在对羰基化合物的不对称还原反应中具有优异的催化活性和对映选择性,还提供了使用该钌配合物制备光学活性醇化合物的催化剂和方法。本发明涉及一种具有钌环结构的钌配合物、用于不对称还原反应的催化剂,以及使用该钌配合物制备光学活性醇化合物的方法。
  • METHOD FOR PRODUCING PKROSTAGLANDIN
    申请人:KYOWA PHARMA CHEMICAL CO., LTD.
    公开号:US20220169600A1
    公开(公告)日:2022-06-02
    The present invention provides a method for producing a compound represented by Formula (1a), (1b), or (1c), comprising a step of reducing a compound represented by Formula (3) in the presence of a metal complex represented by Formula (5), an inorganic base, and a solvent under a hydrogen atmosphere to obtain a compound represented by Formula (4). In the formula, Ar 1 is an aryl group, each Are is independently a phenyl group or the like, W is a biphenyl group or the like, Z is an ethylene group that is substituted with a phenyl group or the like, and L is a chlorine atom or if Z has a phenyl group or a C 1-3 alkoxyphenyl group, L is one of carbon atoms constituting the phenyl group or the C 1-3 alkoxyphenyl group.
    本发明提供了一种制备由公式(1a),(1b)或(1c)表示的化合物的方法,包括在氢气气氛下,在公式(5)表示的金属配合物,无机碱和溶剂的存在下,还原由公式(3)表示的化合物以获得由公式(4)表示的化合物。在该式中,Ar1是芳基基团,每个Are独立地是苯基或类似的基团,W是联苯基团或类似的基团,Z是被苯基或类似基团取代的乙烯基团,如果Z具有苯基或C1-3烷氧基苯基基团,则L是构成苯基或C1-3烷氧基苯基基团的碳原子之一。
  • Optically active diphosphine compound, production intermediates therefor, transition metal complex containing the compound as ligand and asymmetric hydrogenation catalyst containing the complex
    申请人:Takasago International Corporation
    公开号:EP1095946A1
    公开(公告)日:2001-05-02
    This invention provides a novel diphosphine compound which is useful as a ligand of catalysts for asymmetric synthesis reactions, particularly asymmetric hydrogenation reaction. Particularly, it provides a diphosphine compound represented by a general formula (1) : wherein R1 and R2 each independently represents a cycloalkyl group, an unsubstituted or substituted phenyl group or a five-membered aromatic heterocycle residue.
    本发明提供了一种新型二膦化合物,可用作不对称合成反应,特别是不对称氢化反应催化剂的配体。特别是,本发明提供了一种由通式(1)表示的二膦化合物: 其中 R1 和 R2 各自独立地代表环烷基、未取代或取代的苯基或五元芳香杂环残基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐